ConnSante BioTech, Inc.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
1.Cancer Preventive Medicine
2.Cancer Prognosis
3.Cancer drugs R&D
4.Cell therapy & Regenerative medicine
2.Cancer Prognosis
3.Cancer drugs R&D
4.Cell therapy & Regenerative medicine
The content above was translated by Ai
Founded Year
2019
Unified Business No.
54970398
Status
Closed
Number of Employees
9
Total Paid-in
Capital
29,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
ConnSante Biotech is a molecular and cellular information company.
Based on 25-year research, we develop α-score to check the healthy status of stem cell and immune cells which are critical and essential in the war of cancer.
In the past years, we provided diagnostic service for VIP health check-up, ESG staff healthcare program and cancer patient prognosis in our TAF certificated lab.
We are currently working together with doctors to generate clinical evidence on using α-score as a companion diagnosis in lung cancer with specific treatment modality.
We help users to live with a healthy life style in a scientific way.
We work together with doctors, pharmaceutical and biotech companies enroll patients into clinical trials and get a success.
We are ConnSante.
Based on 25-year research, we develop α-score to check the healthy status of stem cell and immune cells which are critical and essential in the war of cancer.
In the past years, we provided diagnostic service for VIP health check-up, ESG staff healthcare program and cancer patient prognosis in our TAF certificated lab.
We are currently working together with doctors to generate clinical evidence on using α-score as a companion diagnosis in lung cancer with specific treatment modality.
We help users to live with a healthy life style in a scientific way.
We work together with doctors, pharmaceutical and biotech companies enroll patients into clinical trials and get a success.
We are ConnSante.
The content above was translated by Ai
Corporate Video
